Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.

PubWeight™: 3.02‹?› | Rank: Top 1%

🔗 View Article (PMID 7705662)

Published in Genes Dev on April 01, 1995

Authors

G Vairo1, D M Livingston, D Ginsberg

Author Affiliations

1: Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Articles citing this

Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev (2000) 6.07

Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A (1997) 5.83

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol (1996) 3.50

E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol (1996) 3.40

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev (1998) 3.01

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A (2000) 2.84

Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol (1996) 2.71

The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47

Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol (1996) 2.46

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci U S A (1996) 2.36

E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol (1997) 2.33

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol (1997) 2.25

The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci U S A (1997) 2.24

A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev (1998) 2.19

Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol (2013) 2.17

Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10

The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci U S A (1998) 2.10

Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol (1997) 2.01

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol (1998) 1.97

In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol (1995) 1.93

Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol (2003) 1.87

Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol (1995) 1.87

Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol (1996) 1.81

Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J (1997) 1.81

Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci U S A (1998) 1.77

Subunit composition determines E2F DNA-binding site specificity. Mol Cell Biol (1997) 1.75

Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol (2008) 1.73

E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol (1999) 1.71

The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol Cell Biol (1998) 1.70

Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol (1996) 1.62

Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol (1997) 1.61

Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J Virol (1995) 1.59

Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol Cell Biol (2001) 1.51

Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci U S A (1996) 1.51

p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol (1998) 1.46

Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J Virol (1996) 1.43

Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42

Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J (1999) 1.39

p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol (1998) 1.39

Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol (1996) 1.37

Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol (2000) 1.35

Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol (2000) 1.32

p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol (1997) 1.31

Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A (1996) 1.29

Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci U S A (1997) 1.23

BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol (1996) 1.22

Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J Virol (2005) 1.22

Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Mol Cell Biol (1999) 1.19

p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16

p107 regulates neural precursor cells in the mammalian brain. J Cell Biol (2004) 1.15

Burkitt's lymphoma: new insights into molecular pathogenesis. J Clin Pathol (2003) 1.14

Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol Cell Biol (1998) 1.14

Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J Virol (1997) 1.13

Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol (1997) 1.10

Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains. Mol Cell Biol (1998) 1.09

Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. Am J Pathol (2000) 1.07

Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection. J Virol (1999) 1.06

E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites. Proc Natl Acad Sci U S A (1997) 1.05

Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. J Virol (1999) 1.04

Cell-context specific role of the E2F/Rb pathway in development and disease. Glia (2010) 1.04

Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J (1999) 0.99

Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J (1998) 0.99

Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Mol Cell Biol (1998) 0.98

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression. Mol Cell Biol (2000) 0.96

Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J Virol (1997) 0.95

p107 in the public eye: an Rb understudy and more. Cell Div (2010) 0.94

J domain-independent regulation of the Rb family by polyomavirus large T antigen. J Virol (2000) 0.94

DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc Natl Acad Sci U S A (1996) 0.93

Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis. J Biol Chem (2006) 0.93

Genomic structure of the human retinoblastoma-related Rb2/p130 gene. Proc Natl Acad Sci U S A (1996) 0.92

E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation. Mol Cell Biol (1999) 0.92

Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion. PLoS Genet (2011) 0.92

Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107. J Virol (1996) 0.91

The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses (2014) 0.90

Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation. Mol Cell Biol (2000) 0.90

Tumor suppressors and cell-cycle proteins in lung cancer. Patholog Res Int (2011) 0.89

Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein. Mol Cell Biol (1998) 0.87

PAM14, a novel MRG- and Rb-associated protein, is not required for development and T-cell function in mice. Mol Cell Biol (2004) 0.85

Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J (1996) 0.85

Control of retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130. Proc Natl Acad Sci U S A (1998) 0.85

In silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers. Cancer Inform (2013) 0.84

p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes. Mol Biol Cell (1997) 0.83

Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice. Mol Vis (2008) 0.82

In vitro analysis of the E1A-homologous sequences of RIZ. J Virol (1997) 0.82

Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen. J Virol (1997) 0.79

Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation. J Exp Clin Cancer Res (2015) 0.79

DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis. Mol Cell Oncol (2015) 0.79

The caudal homeodomain protein activates Drosophila E2F gene expression. Nucleic Acids Res (2002) 0.78

E2F-dependent transcription of the raf proto-oncogene during Drosophila development. Nucleic Acids Res (2001) 0.76

Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem (2017) 0.75

Induction of Wnt/β-catenin signaling in mouse mesenchymal stem cells is associated with activation of the p130 and E2f4 and formation of the p130/Gsk3β/β-catenin complex. Stem Cells Dev (2011) 0.75

Close linkage of p130 and Ft1 is conserved among mammals. Mamm Genome (1998) 0.75

Articles by these authors

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev (1994) 8.92

Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19

Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 6.73

Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell (1991) 6.55

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43

Immunoaffinity chromatography of proteins. Methods Enzymol (1974) 6.40

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92

Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science (2001) 5.58

E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26

Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem (1996) 5.15

Binding and modulation of p53 by p300/CBP coactivators. Nature (1997) 5.12

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A (1994) 5.11

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell (2001) 5.05

T antigen repression of SV40 early transcription from two promoters. Cell (1981) 4.83

An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57

Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56

A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (1995) 4.40

In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature (2000) 4.38

The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell (1991) 4.24

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01

Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet (1994) 3.89

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature (1996) 3.88

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell (1998) 3.86

Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell (1999) 3.83

Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72

Mapping of SV40 DNA replication origin region binding sites for the SV40 T antigen by protection against exonuclease III digestion. Cell (1980) 3.62

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell (1990) 3.61

ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature (2000) 3.48

Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell (1991) 3.47

The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci U S A (1996) 3.43

Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell (2001) 3.43

Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol (1992) 3.37

lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell (1987) 3.33

Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32

Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell (1988) 3.29

p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27

Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev (1996) 3.24

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev (2000) 3.24

E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell (1994) 3.24

Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J Immunol (1972) 3.23

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell (1990) 3.19

The p400 complex is an essential E1A transformation target. Cell (2001) 3.05

E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev (1994) 3.05

An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell (1989) 2.78

Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell (1995) 2.70

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70

Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science (1993) 2.70

The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev (1996) 2.58

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell (1993) 2.57

Control of Saccharomyces cerevisiae 2microN DNA replication by cell division cycle genes that control nuclear DNA replication. J Mol Biol (1977) 2.55

BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1997) 2.55

Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev (1999) 2.51

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell (2000) 2.48

Identification of regions of the SV40 genome which contain preferred SV40 T antigen-binding sites. Cell (1976) 2.47

Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol (1996) 2.40

Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39

Effect of limited homology on gene conversion in a Saccharomyces cerevisiae plasmid recombination system. Mol Cell Biol (1988) 2.37

Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol (1993) 2.37

Relationship of oligomerization to enzymatic and DNA-binding properties of the SV40 large T antigen. Cell (1982) 2.35

Thermolabile T (tumor) antigen from cells transformed by a temperature-sensitive mutant of simian virus 40. Proc Natl Acad Sci U S A (1975) 2.32

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27

Mitotic gene conversion lengths, coconversion patterns, and the incidence of reciprocal recombination in a Saccharomyces cerevisiae plasmid system. Mol Cell Biol (1986) 2.27

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature (1998) 2.25

The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci U S A (1997) 2.24

A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev (1998) 2.19

Interaction of partially purified simian virus 40 T antigen with circular viral DNA molecules. Proc Natl Acad Sci U S A (1975) 2.17

Consensus topography in the ATP binding site of the simian virus 40 and polyomavirus large tumor antigens. Proc Natl Acad Sci U S A (1987) 2.15

Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13

Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13

Expansions of CAG repeat tracts are frequent in a yeast mutant defective in Okazaki fragment maturation. Hum Mol Genet (1998) 2.06

Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus. Virology (1973) 2.05

Inheritance of the 2 micrometer m DNA plasmid from Saccharomyces. Genetics (1977) 2.01

trans-activation of RNA polymerase II and III promoters by SV40 small t antigen. Cell (1988) 1.98

The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci U S A (1992) 1.94

Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88

Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86

Isolation of a condensed, intracellular form of the 2-micrometer DNA plasmid of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1979) 1.81

Partial purification and characterization of the SV40 T antigen. Cell (1974) 1.81

SV40 T antigen: partial purification and properties. Cold Spring Harb Symp Quant Biol (1975) 1.80

Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79

Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci U S A (1998) 1.77

The simian virus 40 large T antigen. A lot packed into a little. Mol Biol Med (1987) 1.77

Smoking cessation and weight gain. J Consult Clin Psychol (1986) 1.77

Role of small t antigen in the acute transforming activity of SV40. Cell (1982) 1.76

p19ARF targets certain E2F species for degradation. Proc Natl Acad Sci U S A (2001) 1.75

E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene (2008) 1.75

Protein kinase activity associated with simian virus 40 T antigen. Proc Natl Acad Sci U S A (1979) 1.72

Deoxyribonucleic acid polymerase III of Escherichia coli. Purification and properties. J Biol Chem (1975) 1.72

Synthesis of simian virus 40 t antigen in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.70

Measurements of the molecular size of the simian virus 40 large T antigen. J Virol (1978) 1.70

A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol (1986) 1.68